Literature DB >> 10373329

Ethnic variation in the thymidylate synthase enhancer region polymorphism among Caucasian and Asian populations.

S Marsh1, E S Collie-Duguid, T Li, X Liu, H L McLeod.   

Abstract

Thymidylate synthase (TS) regulates the production of DNA synthesis precursors and is an important target of cancer chemotherapy. A tandem repeat sequence in a TS promoter enhancer region (TSER) was recently identified. Polymorphic variation affected in vitro expression levels of the gene. We evaluated the influence of ethnicity on TSER genotype. Allele frequency was similar in Caucasian and Southwest Asian subjects. However, homozygous triple repeat subjects were twice as common in Chinese subjects (67%) than in Caucasian subjects (38%). This demonstrates significant ethnic variation in a TS gene regulatory element which may have significant impact on pyrimidine homeostasis and drug therapy. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10373329     DOI: 10.1006/geno.1999.5833

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  35 in total

1.  Association of thymidylate synthase gene polymorphisms with stavudine triphosphate intracellular levels and lipodystrophy.

Authors:  Pere Domingo; M Carmen Cabeza; Alain Pruvost; Ferran Torres; Juliana Salazar; M del Mar Gutierrez; M Gracia Mateo; Angels Fontanet; Irene Fernandez; Joan C Domingo; Francesc Villarroya; Francesc Vidal; Montserrat Baiget
Journal:  Antimicrob Agents Chemother       Date:  2011-01-31       Impact factor: 5.191

2.  TYMS and DPYD polymorphisms in a Turkish population.

Authors:  H S Süzen; N Yüce; G Güvenç; Y Duydu; T Erke
Journal:  Eur J Clin Pharmacol       Date:  2005-11-17       Impact factor: 2.953

3.  Genetic variants in the enhancer region of the thymidylate synthase gene in the Chilean population.

Authors:  M Acuña; L Eaton; L Cifuentes; D Massardo
Journal:  Br J Clin Pharmacol       Date:  2006-06       Impact factor: 4.335

4.  Polymorphisms of thymidylate synthase in the 5'- and 3'-untranslated regions and gastric cancer.

Authors:  Wen Zhuang; Xiao-Ting Wu; Yong Zhou; Guan-Jian Liu; Tai-Xiang Wu; Xun Yao; Liang Du; Mao-Ling Wei
Journal:  Dig Dis Sci       Date:  2008-11-07       Impact factor: 3.199

Review 5.  Identifying genetic variants that contribute to chemotherapy-induced cytotoxicity.

Authors:  Christine M Hartford; M Eileen Dolan
Journal:  Pharmacogenomics       Date:  2007-09       Impact factor: 2.533

6.  Thymidylate synthase genotype-directed neoadjuvant chemoradiation for patients with rectal adenocarcinoma.

Authors:  Benjamin R Tan; Fabienne Thomas; Robert J Myerson; Barbara Zehnbauer; Kathryn Trinkaus; Robert S Malyapa; Matthew G Mutch; Elliot E Abbey; Amer Alyasiry; James W Fleshman; Howard L McLeod
Journal:  J Clin Oncol       Date:  2011-01-04       Impact factor: 44.544

7.  Clinical significance of a novel single nucleotide polymorphism in the 5' untranslated region of the Rabphillin-3A-Like gene in colorectal adenocarcinoma.

Authors:  Venkat R Katkoori; Xu Jia; Chakrapani Chatla; Sanjay Kumar; Selvarangan Ponnazhagan; Tom Callens; Ludwine Messiaen; William E Grizzle; Upender Manne
Journal:  Front Biosci       Date:  2008-01-01

8.  Polymorphism of thymidylate synthase gene associated with its protein expression in human colon cancer.

Authors:  Kai-Huan Yu; Wei-Xing Wang; You-Ming Ding; Hui Li; Ze-Sheng Wang
Journal:  World J Gastroenterol       Date:  2008-01-28       Impact factor: 5.742

Review 9.  Cancer pharmacoethnicity: ethnic differences in susceptibility to the effects of chemotherapy.

Authors:  Peter H O'Donnell; M Eileen Dolan
Journal:  Clin Cancer Res       Date:  2009-07-21       Impact factor: 12.531

10.  Clinical Implications of Body Mass Index in Metastatic Breast Cancer Patients Treated With Abemaciclib and Endocrine Therapy.

Authors:  Maria Alice Franzoi; Daniel Eiger; Lieveke Ameye; Noam Ponde; Rafael Caparica; Claudia De Angelis; Mariana Brandão; Christine Desmedt; Serena Di Cosimo; Nuria Kotecki; Matteo Lambertini; Ahmad Awada; Martine Piccart; Evandro de Azambuja
Journal:  J Natl Cancer Inst       Date:  2021-04-06       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.